Published in N Engl J Med on March 25, 1993
Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry (2010) 3.72
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry (2006) 2.93
Seizure threshold in a large sample: implications for stimulus dosing strategies in bilateral electroconvulsive therapy: a report from CORE. J ECT (2009) 1.99
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT (2013) 1.62
Position statement and guidelines on unmodified electroconvulsive therapy. Indian J Psychiatry (2012) 1.58
Autobiographical memory and electroconvulsive therapy: do not throw out the baby. J ECT (2014) 1.57
Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT (2008) 1.47
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry (2009) 1.24
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx (2006) 1.19
Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study. Eur Arch Psychiatry Clin Neurosci (2012) 1.08
Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract (2009) 1.06
Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT (2010) 1.01
Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci (2008) 0.99
Brain stimulation in psychiatry and its effects on cognition. Nat Rev Neurol (2010) 0.98
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul (2010) 0.96
Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research. Indian J Psychiatry (2008) 0.95
Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates. Neuropsychopharmacology (2010) 0.95
Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry (2008) 0.94
Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. Neuropsychopharmacology (2009) 0.93
Challenges in the treatment of major depressive disorder with psychotic features. Schizophr Bull (2013) 0.92
Fidelity of ECT Devices : An alert to Clinicians. Indian J Psychiatry (2003) 0.92
MRI T(2) relaxometry of brain regions and cognitive dysfunction following electroconvulsive therapy. Indian J Psychiatry (2007) 0.87
ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review. Neuropsychiatr Dis Treat (2012) 0.86
A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis (2012) 0.85
Electroconvulsive therapy--a modern medical procedure. N Engl J Med (1993) 0.84
Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci (2006) 0.82
Meta-analysis of initial seizure thresholds in electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Differential response to right unilateral ECT in depressed patients: impact of comorbidity and severity of illness [ISRCTN39974945]. BMC Psychiatry (2002) 0.82
Repeated dose titration versus age-based method in electroconvulsive therapy: a pilot study. Eur Arch Psychiatry Clin Neurosci (2015) 0.80
Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review. Neural Plast (2015) 0.80
Outcome of electroconvulsive therapy by race in the Consortium for Research on Electroconvulsive Therapy multisite study. J ECT (2008) 0.80
Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT (2014) 0.78
Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London) (2014) 0.78
Searching for the mechanism(s) of ECT's therapeutic effect. J ECT (2014) 0.77
Propofol prevents electroconvulsive-shock-induced memory impairment through regulation of hippocampal synaptic plasticity in a rat model of depression. Neuropsychiatr Dis Treat (2014) 0.77
"Say, are you psychiatrists still using ECT?". CMAJ (1997) 0.77
Images in electroconvulsive therapy: Pilot impressions suggesting that ECT reduces excitatory synapses in the basolateral amygdala. Indian J Psychiatry (2013) 0.77
Predicting Retrograde Autobiographical Memory Changes Following Electroconvulsive Therapy: Relationships between Individual, Treatment, and Early Clinical Factors. Int J Neuropsychopharmacol (2015) 0.76
Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications. J Clin Invest (1994) 0.76
Effects of zopicloone and Lorazepam on ect seizure duration : clinical implications of findings from an animal model. Indian J Psychiatry (2000) 0.76
Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review. Clin Psychopharmacol Neurosci (2013) 0.76
Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT. Indian J Psychol Med (2011) 0.75
Computer-Assisted Cognitive Behavior Therapy to Prevent Relapse Following Electroconvulsive Therapy. J ECT (2016) 0.75
Pre-treatment amygdala volume predicts electroconvulsive therapy response. Front Psychiatry (2014) 0.75
Is a grandmal seizure necessary and sufficient for the efficacy of electro convulsive therapy? Indian J Psychiatry (2000) 0.75
Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy: Focal Electrically Administered Seizure Therapy. J ECT (2016) 0.75
ECT practices in Iraq: a national audit. BJPsych Bull (2015) 0.75
Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia. J ECT (2010) 0.75
Delayed Onset and Prolonged ECT-Related Delirium. Case Rep Psychiatry (2013) 0.75
Rational electroconvulsive therapy electrode placement. Psychiatry (Edgmont) (2005) 0.75
Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy. J ECT (2017) 0.75
[Adverse cognitive effects and ECT]. Wien Med Wochenschr (2006) 0.75
[Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease]. Wien Klin Wochenschr (2003) 0.75
Seizure threshold increases can be predicted by EEG quality in right unilateral ultrabrief ECT. Eur Arch Psychiatry Clin Neurosci (2017) 0.75
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA (2001) 4.34
Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther (1994) 4.18
Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care (2001) 4.07
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol (1998) 2.49
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry (1999) 1.77
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol (1990) 1.71
Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61
Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry (1996) 1.56
Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT (2000) 1.56
The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry (1996) 1.53
Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry (1987) 1.51
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry (2011) 1.50
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med (1993) 1.45
Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry (1997) 1.44
Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. J ECT (2000) 1.44
A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol (2005) 1.42
Does ECT permanently alter seizure threshold? Biol Psychiatry (1993) 1.41
Nutritional status in patients with rheumatoid arthritis. Ann Rheum Dis (1984) 1.39
Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry (1998) 1.38
Predictors of retrograde amnesia following ECT. Am J Psychiatry (1995) 1.35
Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res (1990) 1.32
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am (1991) 1.27
Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep (2006) 1.26
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology (2002) 1.25
Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev (1999) 1.23
Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry (2009) 1.23
The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc (1999) 1.15
Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. J Am Geriatr Soc (2003) 1.12
Relationships between certification and job perceptions of oncology nurses. Oncol Nurs Forum (2001) 1.10
Individual pulmonary vein size and survival in infants with totally anomalous pulmonary venous connection. J Am Coll Cardiol (1993) 1.03
ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord (2001) 1.03
Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry (1999) 1.03
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatry (2008) 1.01
Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry (1990) 0.98
Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr (1992) 0.97
An analysis of printed breast cancer information for African American women. J Cancer Educ (2000) 0.94
Unique features and prognosis of primum ASD presenting in the first year of life. Circulation (1994) 0.93
Assessment of late life depression. Biol Psychiatry (2002) 0.93
The development of mania and organic euphoria during ECT. J Clin Psychiatry (1988) 0.92
Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics (2000) 0.92
Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsychopharmacology (1999) 0.92
A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology (1996) 0.91
Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry (2002) 0.91
Continuation therapy following ECT: directions for future research. Psychopharmacol Bull (1994) 0.90
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease. Int J Geriatr Psychiatry (2009) 0.90
A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]. Brain Stimul (2013) 0.89
Homocysteine levels, MTHFR C677T genotype, and MRI Hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry (2005) 0.89
Acute effects of ECT on cardiovascular functioning: relations to patient and treatment variables. Acta Psychiatr Scand (1987) 0.88
Speed of processing and depression affect function in older adults with mild cognitive impairment. Am J Geriatr Psychiatry (2013) 0.87
Exceptionally high seizure threshold: ECT device limitations. Convuls Ther (1996) 0.87
Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am (1991) 0.87
Changes in the serum concentrations of thyroxine-binding prealbumin and retinol-binding protein following burn injury. Clin Chim Acta (1982) 0.87
Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. J ECT (2000) 0.87
Consequences of antipsychotic medications for the dementia patient. Am J Psychiatry (2011) 0.86
Acute cognitive effects of subconvulsive electrical stimulation. Convuls Ther (1994) 0.86
Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Arch Gen Psychiatry (1994) 0.86
Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. J ECT (2000) 0.86
Are there sensitive time periods for dementia caregivers? The occurrence of behavioral and psychological symptoms in the early stages of dementia. Int Psychogeriatr (2013) 0.86
Depression in the first year of stay for elderly long-term nursing home residents in the USA. Int Psychogeriatr (2010) 0.85
Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. Convuls Ther (1997) 0.85
The differential impact of unique behavioral and psychological symptoms for the dementia caregiver: how and why do patients' individual symptom clusters impact caregiver depressive symptoms? Am J Geriatr Psychiatry (2013) 0.85
Visual fixation and smooth pursuit eye movement abnormalities in patients with schizophrenia and their relatives. J Neuropsychiatry Clin Neurosci (1995) 0.85
Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry (1999) 0.84
Is dysthymia a different disorder in the elderly? Am J Psychiatry (1994) 0.84
Coupled cognitive and functional change in Alzheimer's disease and the influence of depressive symptoms. J Alzheimers Dis (2013) 0.84